Sophia Sanjay

Sophia Sanjay

@aidigihealth

3 المنشورات

0 الصور

0 الفيديوهات

يعيش في Springfield

من Mumbai City

Male

0 متابعين

المنشورات

الأصدقاء

الفيديوهات

المجموعات

المناسبات

Web Marketing Executive لدى WiseGuy Reports

درس WEB MARKETING لدى Harvard University

فئة من MBA in Healthcare

التحديثات الأخيرة

Sophia Sanjay @aidigihealth أضاف وظيفة جديدة in Health
2025-11-06 10:08:05 ·

Regulatory Bodies Navigate Complexity to Accelerate Personalized Medicine Approvals; Balancing Innovation with Safety in a Dynamic Market

Regulatory approval processes are critical to the personalized medicine market’s growth, yet they face unique challenges. Unlike traditional drugs, personalized therapies often target rare genetic subtypes, have smaller patient cohorts, and rely on novel biomarkers—factors that complicate traditional efficacy and safety assessments. Agencies like the FDA, EMA, and China’s NMPA...

0 التعليقات ·0 المشاركات ·16 مشاهدة ·0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Sophia Sanjay @aidigihealth أضاف وظيفة جديدة in Health
2025-11-06 09:49:10 ·

Tech-Driven Evolution: AI and Digital Tools Reshape India’s CRO Sector for Faster Drug Development

India’s contract research organizations (CROs) are undergoing a technological revolution, with artificial intelligence (AI), machine learning (ML), and advanced analytics driving efficiency and innovation across drug development workflows. From preclinical data analysis to post-trial reporting, CROs are leveraging digital tools to reduce timelines, minimize errors, and lower costs,...

0 التعليقات ·0 المشاركات ·17 مشاهدة ·0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Sophia Sanjay @aidigihealth أضاف وظيفة جديدة in Health
2025-11-06 09:33:13 ·

Patent Expirations Ignite Generic Injectables Market Expansion: Key Drugs and Industry Responses

A wave of patent expirations for high-revenue branded injectables is propelling the generic injectables market into uncharted territory. Over the next five years, patents for drugs like adalimumab (Humira, though biosimilar), pantoprazole, and cisplatin are set to expire, opening multi-billion-dollar opportunities for generic manufacturers. This trend not only lowers patient costs but also...

0 التعليقات ·0 المشاركات ·15 مشاهدة ·0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!

المزيد من المنشورات